Picture loading failed.

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. The relationship of cervical cancer and sexual behavior was suspected for more than 100 years and was established by epidemiologic studies in the 1960s. In the early 1980s, cervical cancer cells were demonstrated to contain HPV DNA. Epidemiologic studies showing a consistent association between HPV and cervical cancer were published in the 1990s. The first vaccine to prevent infection with four types of HPV was licensed in 2006.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-Human papilloma virus (HPV) monoclonal antibody for rapid test kit of Human papilloma virus (HPV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-HPV-1Ab-1mg 1mg 1490
GMP-HPV-1Ab-10mg 10mg 8960
GMP-HPV-1Ab-100mg 100mg 44800
GMP-HPV-1Ab-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Antigen & Antibody Name Mouse anti-Human papilloma virus (HPV) monoclonal antibody
Host specics Hybridoma
Source (Expression Host)Mouse IgG
Bioactivity validationAntibody Binding, Immunogen in Sandwich Elisa, anteral-flow tests, and other immunoassays in[Human papilloma virus (HPV)] level test in human infectious disease diagnositcs.
TagmFc
Products descriptionHuman papillomavirus (HPV) is the most common sexually transmitted infection in the United States. The relationship of cervical cancer and sexual behavior was suspected for more than 100 years and was established by epidemiologic studies in the 1960s. In the early 1980s, cervical cancer cells were demonstrated to contain HPV DNA. Epidemiologic studies showing a consistent association between HPV and cervical cancer were published in the 1990s. The first vaccine to prevent infection with four types of HPV was licensed in 2006.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;
FormulationSupplied as a 0.2 μM filtered solution of PBS,PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.